Literature DB >> 23279259

Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis.

O Simonetti1, G Lucarini, C Rubini, G Goteri, A Zizzi, S Staibano, A Campanati, G Ganzetti, R Di Primio, A Offidani.   

Abstract

OBJECTIVE: To understand the role of angiogenesis and hypoxia in cancer progression of primary oral melanoma (POM).
MATERIALS AND METHODS: Sixteen malignant primary melanomas were immunostained with markers CD34, VEGF and HIF-1α. Stained cells were counted in the invasive front and inside the tumour, and the differences were compared and correlated with histological parameters and disease-specific survival of the patients.
RESULTS: Tumour invasive front showed increased MVD and increased vessel VEGF and HIF-1α expression compared with the intratumoural compartment. No such differences were seen in tumoural melanocytes of the two compartments. Positive correlations were observed between CD34 and VEGF, CD34 and HIF-1α and VEGF and HIF-1α expression in invasive front vessels. CD34 expression was statistically correlated with the level of infiltration. A significant trend to worse disease-free survival was also determined with increased invasive front vessel expression of CD34, VEGF and HIF-1α.
CONCLUSIONS: Our data highlight the importance of the invasive margin in POM biology. The high angiogenic activity and endothelial VEGF and HIF-1α expression in invasive front vessels have a significant impact on patient survival and future agents targeted against VEGF pathway may represent a novel and effective therapeutic opportunity. Larger studies are needed to further address our findings.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIF-1α; MVD; VEGF; invasive margin; oral melanoma; survival

Mesh:

Substances:

Year:  2012        PMID: 23279259     DOI: 10.1111/odi.12048

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  11 in total

1.  Melanoma of the Oral Cavity: an Analysis of 46 New Cases with Emphasis on Clinical and Histopathologic Characteristics.

Authors:  Molly Housley Smith; Indraneel Bhattacharyya; Donald M Cohen; Nadim M Islam; Sarah G Fitzpatrick; Lindsay J Montague; Douglas D Damm; Craig B Fowler
Journal:  Head Neck Pathol       Date:  2016-01-11

2.  Functional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude mice.

Authors:  Jianqiu Chen; Qi Zhou; Chunsheng Zhu; Minhui Zhu; Yongsheng Tian; Guojun Li; Xiaofeng Tao; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.

Authors:  Zhen Wang; Peng Wen; Xiaojun Luo; Xiaomin Fang; Qingfeng Wang; Feng Ma; Jinhan Lv
Journal:  Tumour Biol       Date:  2013-12-06

4.  Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.

Authors:  Youliang Wu; Dapeng Yun; Yingjie Zhao; Yuqi Wang; Ruochuan Sun; Qiang Yan; Shangxin Zhang; Mingdian Lu; Zhen Zhang; Daru Lu; Yongxiang Li
Journal:  Oncotarget       Date:  2017-01-03

5.  Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst.

Authors:  Shokoofeh Jamshidi; Massoumeh Zargaran; Ghodratollah Roshanaei; Fatemeh Hadadi; Ali Dehghani Nazhvani
Journal:  J Dent (Shiraz)       Date:  2017-03

6.  Expression of VEGF in human conjunctival melanoma analyzed with immunohistochemistry.

Authors:  Satoru Kase; Iku Kikuchi; Susumu Ishida
Journal:  Clin Ophthalmol       Date:  2018-11-19

7.  Effects of Stellera chamaejasme on microvascular density and apoptosis of cancer cells in a rat bladder tumor model.

Authors:  Yudong Huang; Jun Zhang; Baolin Zhang; Shuang Chen; Ziyang Qiang; Hailin Ren; Guojun Chen; Chengde Ren
Journal:  Transl Androl Urol       Date:  2022-03

8.  Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy.

Authors:  Qiaoling Sun; Jinghong Zhou; Zheng Zhang; Mingchuan Guo; Junqing Liang; Feng Zhou; Jingwen Long; Wei Zhang; Fang Yin; Huaqing Cai; Haibin Yang; Weihan Zhang; Yi Gu; Liang Ni; Yang Sai; Yumin Cui; Meifang Zhang; Minhua Hong; Junen Sun; Zheng Yang; Weiguo Qing; Weiguo Su; Yongxin Ren
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer.

Authors:  Shuai Liu; Lu Lu; Feng Pan; Chunsheng Yang; Jing Liang; Jinfeng Liu; Jian Wang; Rong Shen; Fu-Ze Xin; Nan Zhang
Journal:  Oncol Res       Date:  2022-01-21       Impact factor: 4.938

10.  Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.

Authors:  Chie Nakashima; Tadaaki Kirita; Kazuhiko Yamamoto; Shiori Mori; Yi Luo; Takamitsu Sasaki; Kiyomu Fujii; Hitoshi Ohmori; Isao Kawahara; Takuya Mori; Kei Goto; Shingo Kishi; Rina Fujiwara-Tani; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.